Antibacterial Drugs Market 2019-2024
08-Jan-2019 | Number of pages: 192 | Report Id: BMRC PH 134 | Report Format: | Status: Published

Antibacterial Drugs Market By Drug Class (B-lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside), By Route of Administration (Enteral, Parenteral), Industry Analysis, Trends, and Forecast 2019 – 2024

Antibacterial Drugs Market is valued around USD 45864.58 Million in 2017 and expected to reach USD 50204.61 Million by 2024 with the CAGR of 1.3% over the forecast period. Increased prevalence of infectious disease and increased demand for efficient antibacterial drugs is the key drivers for Global Antibacterial Drugs Market

Antibacterial Drugs market report published by the Brandessence Market Research and Consulting Pvt. Ltd. provides the detail information about antibacterial drugs market from various aspects. This report consists of drivers, restrains, Opportunities which help the market to grow over the analysis period and recent trends which support the growth of market. This report consists of regional segmentation with drug class, route of administration, distribution channel.

Antibacterial drugs are those drugs which can kill or inhibit the growth of microorganism such as bacteria, virus, fungi and others. Antibacterial drugs are mostly used for the treatment of prevention of infectious disease caused due to such microorganisms. There are different classes of antibacterial drugs available in the market according to the microorganisms. Antibiotics are widely being used in the healthcare practices apart from treating chronic infections they are used in medical procedures such as organ transplantation, chemotherapy and surgical operations. These procedures carry high risk of chronic bacterial infection due to which antibacterial drugs are in great demand. The global antibacterial drugs market has also been impacted by several new drugs launched in the market these novel antibiotics act as an insurance mechanism against the future impact of resistance.

Antibacterial Drugs Market Analysis

There are various factors driving the growth of the antibacterial drugs market, one of the major driving the growth of the market is increased prevalence of infectious disease over the period of time. As per Centers for Disease Control and Prevention 2017 report, around 16.8 million people in the U.S. visit physician office due to the infectious and parasitic diseases. Furthermore, geriatric population is more prone to infectious disease due to the weak immune system and growing geriatric population is expected to fuel the growth of antibacterial drugs market. Moreover, increased demand of efficient antibacterial drugs is also expected to support the growth of antibacterial drugs market. Increase in antibacterial resistance and increasing demand for novel drugs are expected to promote the growth of antibacterial drugs market. However, increase use of generic drugs patent expiry is expected inhibit the growth of antibacterial drugs market over the forecast period.

Antibacterial Drugs Market Share

Antibacterial Drugs Market Revenue (USD Million) Analysis by Regional and Global, 2018-2024

Global antibacterial drugs market report covers prominent players like Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Allergen Plc., Novartis Ag, AstraZeneca, Bayer AG, Merck & Co., Inc., Johnson and Johnson, Bristol Myers Squibb Company, and others.

Antibacterial Drugs Market Segmentation –

By Drug Class 

  • B-lactams
  • Quinolones
  • Macrolides
  • Tetracycline
  • Aminoglycoside
  • Sulfonamide
  • Phenicols
  • Others

By Route of Administration 

  • Enteral
  • Parenteral
  • Others

By Distribution Channel 

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Sales

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Antibacterial Drugs Market Key Players

Pfizer Inc.
Sanofi
GlaxoSmithKline Plc. (GSK)
Allergen Plc.
Novartis Ag
AstraZeneca
Bayer AG
Merck & Co., Inc.

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Antibacterial Drugs Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Antibacterial Drugs Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Antibacterial Drugs Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Antibacterial Drugs Market Overview: Quantitative Analysis
    • Global Antibacterial Drugs Market Consumption, Market Share ( %) and Growth Rate, 2015-2025
    • Global Antibacterial Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2015-2025
  2. Chapter – Global Antibacterial Drugs Market Analysis: by Drug Class
  3. Chapter – Global Antibacterial Drugs Market Analysis: by Route of Administration
  4. Chapter – Global Antibacterial Drugs Market Analysis: by Distribution Channel
  5. Chapter – Global Antibacterial Drugs Market Analysis: by Manufacturer
    • Global Antibacterial Drugs Market Revenue (USD Million), by Manufacturer, 2015-2018
    • Global Antibacterial Drugs Market Consumption, Manufacturer, 2015-2018
    • Global Antibacterial Drugs Market Share (%), by Manufacturer, 2018
    • Global Antibacterial Drugs Market Price (USD/Unit), by Manufacturer, 2015-2018
    • Global Antibacterial Drugs Market Revenue Growth Rate (%), by Manufacturer, 2015-2018
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  6. Chapter – Antibacterial Drugs Market: Regional Analysis
    • North America
      • North America Antibacterial Drugs Market Revenue (USD Million) and Growth Rate (%), 2015-2025.
      • North America Antibacterial Drugs Market Revenue (USD Million) By Country, 2015-2025.
      • North America Antibacterial Drugs Revenue Market Share (%) By Country, 2015-2025.
      • North America Antibacterial Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
      • North America Antibacterial Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
      • North America Antibacterial Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2015-2025.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  7. Chapter – Company Profiles
    • Pfizer Inc.
      • Overview
      • Financials
      • Product portfolio
      • Antibacterial Drugs Market Revenue (USD Million), Consumption  and Market Share (%), 2014 – 2017
      • Antibacterial Drugs Sales Market Share (%), 2014 – 2017
      • Business strategy
      • Recent developments
    • Sanofi
    • GlaxoSmithKline Plc. (GSK)
    • Allergen Plc.
    • Novartis Ag
    • AstraZeneca
    • Bayer AG
    • Merck & Co., Inc.
    • Johnson and Johnson
    • Bristol Myers Squibb Company
    • Others
  8. Chapter – Market Research and Findings

Pfizer Inc.
Sanofi
GlaxoSmithKline Plc. (GSK)
Allergen Plc.
Novartis Ag
AstraZeneca
Bayer AG
Merck & Co., Inc.
Johnson and Johnson
Bristol Myers Squibb Company
Others